AGP Executive Report
Last update: 9 hours agoCannabis Use Guidance: Scientists say “lower dose and frequency” generally means lower risk, but there’s no standard unit because today’s products aren’t consistent—so “how much is okay” depends on the person. US Policy & Health: A Chicago study links hotter days to more ER visits and notes cannabinoid-related effects can worsen during heat spikes. Legal Market Culture: New York’s legal cannabis is leaning into community identity, with a family-owned brand pitching “good weed, made by real people” as the next phase of legalization. International Medicinal Cannabis: Costa Rica opened its first medicinal cannabis manufacturing lab, aiming to move from raw exports to finished oils, syrups, pills—and potentially create hundreds of jobs. Regulatory/Compliance: Thailand’s Pattaya is setting rules for visiting US sailors, including bans on marijuana use and access to cannabis shops, as local enforcement ramps up. Industry Expansion: Grön launched its Pearls edibles in four new US states, betting on consistent dosing and multi-state rollout. Enforcement & Risk: Separate reporting flags kratom’s rising health concerns and federal scheduling pressure on certain kratom-related compounds.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
